ARGENX SE Noncurrent Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income
ARGENX SE (ARGX) had Noncurrent Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income of $10.02 million as of 2025-12-31, per its 20-F filed 2026-03-19.
Financial Statements › Notes › Equity
ifrs-full:NoncurrentInvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncome · last filed 2026-03-19
- 2025-12-31: Noncurrent Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income $10.02M.
- 2024-12-31: Noncurrent Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income $14.88M.
- 2024-06-30: Noncurrent Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income $9.85M.
- 2023-12-31: Noncurrent Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income $15.53M.
| Period end | Noncurrent Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income |
|---|---|
| 2025-12-31 | $10.02M 20-F · filed 2026-03-19 |
| 2024-12-31 | $14.88M 20-F · filed 2026-03-19 |
| 2024-06-30 | $9.85M 6-K · filed 2024-07-25 |
| 2023-12-31 | $15.53M 20-F · filed 2026-03-19 |
| 2023-06-30 | $15.76M 6-K · filed 2023-07-27 |
| 2022-12-31 | $17.44M 20-F · filed 2025-03-20 |
| 2021-12-31 | $35.71M 20-F · filed 2024-03-21 |